ECM
GOSS icon

ExodusPoint Capital Management’s Gossamer Bio GOSS Stock Holding History

ExodusPoint Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-105,056
Closed -$116K – 1654
2025
Q1 		$116K Buy
+105,056
New +$121K ﹤0.01% 1339
2024
Q2 		– Sell
-180,987
Closed -$214K – 1689
2024
Q1 		$214K Buy
+180,987
New +$199K ﹤0.01% 1335
2023
Q2 		– Sell
-163,769
Closed -$206K – 1996
2023
Q1 		$206K Buy
+163,769
New +$313K ﹤0.01% 1570
2022
Q4 		– Sell
-24,571
Closed -$294K – 1811
2022
Q3 		$294K Buy
+24,571
New +$305K ﹤0.01% 1530
2022
Q2 		– Sell
-17,865
Closed -$155K – 2127
2022
Q1 		$155K Buy
+17,865
New +$172K ﹤0.01% 1956
2021
Q4 		– Sell
-36,443
Closed -$458K – 2330
2021
Q3 		$458K Sell
36,443
-1,100
-3% -$10.1K 0.01% 1447
2021
Q2 		$305K Buy
+37,543
New +$326K ﹤0.01% 1730
2020
Q3 		– Sell
-44,317
Closed -$576K – 1924
2020
Q2 		$576K Buy
+44,317
New +$557K 0.02% 1005

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ExodusPoint Capital Management's GOSS Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 105,056 shares — an estimated $116K sold.

ExodusPoint Capital Management first reported a position in GOSS in Q2 2020 and held it in 8 quarters. The position peaked at $576K in Q2 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 105,056 Gossamer Bio shares in Q2 2025, an estimated $116K.
  • ExodusPoint Capital Management first reported a position in Gossamer Bio in Q2 2020 and held it in 8 quarters.
  • ExodusPoint Capital Management's Gossamer Bio position peaked at $576K in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.